Vimarsana
Biggest News Aggregation in the World

Nasdaq Snse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Snse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Snse Today - Breaking & Trending Today

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Update - Vimarsana News

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Update

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 81,000 shares, a drop of 48.1% from the March 31st total of 156,200 shares. Based on an average trading volume of 69,200 shares, […]

Newtyn Management LLC Sells 27,240 Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) - Vimarsana News

Newtyn Management LLC Sells 27,240 Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE)

Newtyn Management LLC reduced its stake in shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Free Report) by 1.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,800,000 shares of the company’s stock after selling 27,240 shares during the period. Newtyn Management LLC owned approximately […]

Sensei Biotherapeutics (NASDAQ:SNSE) Trading 9.4% Higher - Vimarsana News

Sensei Biotherapeutics (NASDAQ:SNSE) Trading 9.4% Higher

Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) traded up 9.4% on Wednesday . The company traded as high as $0.73 and last traded at $0.71. 66,475 shares were traded during trading, an increase of 40% from the average session volume of 47,530 shares. The stock had previously closed at $0.65. Sensei Biotherapeutics […]

Sensei Biotherapeutics to Present Initial Clinical Data - Vimarsana News

Sensei Biotherapeutics to Present Initial Clinical Data

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery...

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Significant Growth in Short Interest - Vimarsana News

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Significant Growth in Short Interest

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Rating) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 183,100 shares, an increase of 72.4% from the April 15th total of 106,200 shares. Approximately 1.1% of the shares of the company are short sold. Based on […]